The Parkinson's disease sleep scale:: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease

被引:511
作者
Chaudhuri, KR
Pal, S
DiMarco, A
Whately-Smith, C
Bridgman, K
Mathew, R
Pezzela, FR
Forbes, A
Högl, B
Trenkwalder, C
机构
[1] Kings Coll Hosp London, Dept Neurol, London SE5 9RS, England
[2] Univ Hosp Lewisham, London, England
[3] Kings Coll London, Guys Kings & St Thomas Sch Med, London WC2R 2LS, England
[4] Univ Gottingen, Dept Clin Neurophysiol, D-3400 Gottingen, Germany
[5] Univ Roma La Sapienza, Dept Neurol Sci, I-00185 Rome, Italy
[6] Pharmacia Ltd, Milton Keynes, Bucks, England
[7] Max Planck Inst Psychiat, D-80804 Munich, Germany
关键词
D O I
10.1136/jnnp.73.6.629
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: No formal instruments are available for quantifying sleep problems in Parkinson's disease. Objective: To develop a new sleep scale to quantify the various aspects of nocturnal sleep problems in Parkinson's disease, which may occur in up to 96% of affected individuals. Methods: Employing a multidisciplinary team approach, a visual analogue scale was devised addressing 15 commonly reported symptoms associated with sleep disturbance in Parkinson's disease-the Parkinson's disease sleep scale (PDSS). In all, 143 patients with Parkinson's disease completed the PDSS, covering the entire spectrum of disease from newly diagnosed to advanced stage. As controls, 137 age healthy matched subjects also completed the scale. Test-retest reliability was assessed in a subgroup of subjects. The Epworth sleepiness scale was also satisfactorily completed by 103 of the patients with Parkinson's disease. Results: PDSS scores in the Parkinson group were significantly different from the healthy controls. Patients with advanced Parkinson's disease had impaired scores compared with early/moderate disease. Individual items of the scale showed good discriminatory power between Parkinson's disease and healthy controls. Relevant items of the PDSS correlated with excessive daytime sleepiness. The scale showed robust test-retest reliability. Conclusions: This appears to be the first description of a simple bedside screening instrument for evaluation of sleep disturbances in Parkinson's disease. A combination of subitems may help identify specific aspects of sleep disturbance, which in turn may help target treatment.
引用
收藏
页码:629 / 635
页数:7
相关论文
共 34 条
[1]   Measuring quality of life - Who should measure quality of life? [J].
Addington-Hall, J ;
Kalra, L .
BRITISH MEDICAL JOURNAL, 2001, 322 (7299) :1417-1420
[2]  
[Anonymous], EUR J NEUROL
[3]   Improvement of sleep architecture in PD with subthalamic nucleus stimulation [J].
Arnulf, I ;
Bejjani, BP ;
Garma, L ;
Bonnet, AM ;
Houeto, JL ;
Damier, P ;
Derenne, JP ;
Agid, Y .
NEUROLOGY, 2000, 55 (11) :1732-1734
[4]   Parkinson's disease and sleepiness - An integral part of PD [J].
Arnulf, I ;
Konofal, E ;
Merino-Andreu, M ;
Houeto, JL ;
Mesnage, V ;
Welter, ML ;
Lacomblez, L ;
Golmard, JL ;
Derenne, JP ;
Agid, Y .
NEUROLOGY, 2002, 58 (07) :1019-1024
[5]  
Arnulf I, 2001, NEUROLOGY, V56, pA307
[6]  
ASKENASY JJM, 1993, ACTA NEUROL SCAND, V87, P167
[7]   Achieving 24-hour control of Parkinson's disease symptoms: Use of objective measures to improve nocturnal disability [J].
Chaudhuri, KR ;
Pal, S ;
Bridgman, K ;
Trenkwalder, C .
EUROPEAN NEUROLOGY, 2001, 46 :3-10
[8]  
CHAUDHURI KR, 2001, J NEUROL SCI, V395, pP1162
[9]  
Fahn S., 1987, RECENT DEV PARKINSON, P153
[10]  
Fayers P. M., 2008, QUALITY LIFE ASSESSM, DOI 10.1111/j.1541-0420.2008.01082_11.x